Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex

British Journal of Cancer

Volumn 74, Issue 7, 1996, Pages 1037-1045

  O'Neill, C F ^a   Ormerod, M G ^a   Robertson, D ^a   Titley, J C ^a   Cumber Walsweer, Y ^a   Kelland, L R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Apoptosis; Cis trans platinum analogues

Indexed keywords

CIS AMMINEDICHLORO(CYCLOHEXYLAMINE)DIHYDROXOPLATINUM; CISPLATIN; DNA FRAGMENT; TRANS AMMINEDICHLORO(CYCLOHEXYLAMINE)DIHYDROXOPLATINUM;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL LYSATE; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG EFFECT; HUMAN; HUMAN CELL; KINETICS; OVARY CARCINOMA; PRIORITY JOURNAL; TIME;

EID: 0029784954     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.486     Document Type: Article

References (37)

1. ARENDS MJ AND WYLLIE AH. (1991). Apoptosis, mechanisms, role in pathology. Int. Rev. Exp. Pathol., 32, 223 254.
2. ARENDS MJ, MORRIS RG AND WYLLIE AH. (1990). Apoptosis: the role of the endonucleases. Am. J. Pathol., 136, 593 607.
3. BARRY MA, BEHNKE CA AND EASTMAN A. (1990). Activation of a programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hypothermia. Biochem. Pharmacol., 40, 2353 2362.
4. BEALE P, SHARPSY, WALTON MI AND KELLAND LR. (1996). Bcl-2 and chemosensitivity in human ovarian carcinoma cell lines (abstract). Proc. Am. Assoc. Cancer Res., 37, 210.
5. BROWN DG, SUN XM AND COHKN GM. (1993). Dexamethasone induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem., 268, 3037 3039.
6. BURTON K. (1956). A study of the condition and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J., 62, 315 323.
7. COHEN GM, SUN XM, SNOWDEN RT, DINSDALE D AND SKILLETER DN. (1992). Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J., 286, 331-334.
8. COLLINS RJ, HARMON BV, GOBE GC AND KERR JFR. (1992). Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol., 61, 451-453.
9. COMPTON MM. (1992). A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev., 11, 105 119.
10. DIVE C AND HICKMAN JA. (1991). Drug-target interactions: only the first step in the commitment to a programmed cell death? Br. J. Cancer, 64, 192 196.
11. EVANS DL AND DIVE C. (1993). Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and non proliferating immature thymocytes. Cancer Res., 53, 2133 2139.
12. GORCZYCA W, GONG J, ARDELT B, TRAGANOS F AND DARZYNKIEWICZ. (1993). The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res., 53, 3186 3192.
13. HANSSON J, LWEWNSHON R AND RINGBORG U. (1988). Cis-diamminedi-chloroplatinum(II) toxicity in human melanoma cells and lymphocytes as related to cellular platinum accumulation, DNA cross-linking and inhibition of DNA synthesis. Acta. Oncol., 27, 383-392.
14. HARMON BV, CORDER AM , COLLINS RJ, GOBE GC, ALLEN J, ALLAN DJ AND KERR JFR. (1990). Cell death induced in a murine mastocytoma by 42-47°C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above critical heat load, Int. J. Radiat. Biol., 58, 845-853.
15. HICKMAN JA. (1992). Apoptosis induced by anticancer drugs. Cancer Metastasis Rev., 11, 121-139.
16. KAUFMANN SH. (1989). Induction of endonucleocytic DNA cleavage in human acute myelogenous leukaemic cells by etoposide, camptothecin and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49, 5870-5878.
17. KELLAND LR, MISTRY P, ABEL G, LOH SY, O'NEILL CF, MURRER BA AND HARRAP KR. (1992). Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/ amine platinum(IV) dicarboxylates. Cancer Res., 52, 3857 3864.
18. KELLAND LR, BARNARD CFJ, MELLISH KJ, JONES M, GODDARD PM, VALENTI M, BRYANT A, MURRER BA AND HARRAP KR. (1994). A novel trans-platinum coordination complex possessing in vitro and in vivo antitumour activity. Cancer Rex., 54, 5618-5622.
19. KERR JFR, WINIRFORD CM AND HARMON BV. (1994). Apoptosis its significance in cancer and cancer therapy. Cancer, 73, 2013 2026.
20. LIU LF. (1989). DNA topoisomerase poisons as anti-tumour drugs. Ann. Rev. Biochem., 58, 351-371.
21. MELLISH KJ, BARNARD CFJ, MURRER BA AND KELLAND LR, (1995). DNA-binding properties of novel cis and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines. Int. J. Cancer, 62, 711 723.
22. MEYN RE, CLIFTON STEPHENS L, HUNTER NR AND MILAS L. (1995). Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int. J. Cancer, 60, 725-729.
23. MILAS L, HUNTER NR, KURDOGLU B, MASON KA, MEYN RE, STEPHENS LC AND LESTER PJ. (1995). Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother. Pharmacol., 35, 297-303.
24. OBERHAMMER F, WILSON JW, DIVE C, MORRIS ID, HICKMAN JA, WAKELING AE, WALKER PR AND SIKORSKA M. (1993). Apoptotic death in epithelial cells, cleavage of DNA to 300 and/ or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J., 12, 3679-3684.
25. O'NEILL CF, ORR RM, KELLAND LR AND HARRAP KR. (1995). Comparison of platinum binding to DNA and removal of total platinum adducts and interstrand cross-links in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin. Cellular Pharmacol., 2, 1-7.
26. ORMEROD MG. (1994). Further applications to cell biology In Flow Cytometry: a Practical Approach, Ormerod MG. (ed.) pp. 261-273. IRL Press at Oxford University Press: Oxford.
27. ORMEROD MG, ORR RM AND PEACOCK JH. (1994a). The role of apoptosis in cell killing by cisplatin: a flow cytometric study. Br. J. Cancer, 69, 93-100.
28. ORMEROD MG, O'NEILL CF, ROBERTSON D AND HARRAP KR. (1994b). Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp. Cell. Res., 211, 231-237.
29. ORMEROD M, O'NEILL C, ROBERTSON D, KELLAND LR AND HARRAP KR. (1996). Cis-diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemother. Pharmacol., 37, 463-471.
30. SMITH PJ, RACKSTRAW C AND COTTER F. (1994). DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells. Ann. Hematol., 69, S7-S11.
31. 2 phase and cell death induced by cisplatin. J. Natl Cancer Inst., 82, 749-755.
32. WALKER PR, SMITH C, YOUDALE T, LEBLANC J, WHITFIELD JF AND SIKORSKA M. (1991). Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res., 51, 1078-1085.
33. WALTON MI, WU E, SHARP SY AND KELLAND LR. (1996). p53 status and CDDP sensitivity in a panel of ovarian carcinoma cell lines (abstract). Proc. Am. Assoc. Cancer Res., 37, 2747.
34. WOOD AC, WATERS CM, GARNER A AND HICKMAN JA. (1994). Changes in c-myc expression and the kinetics of dexamethasone-induced programmed cell death (apoptosis) in human lymphoid cells. Br. J. Cancer, 69, 663-669.
35. WOOD AC, ELVIN P AND HICKMAN JA. (1995). Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression. Br. J. Cancer, 71, 973-941.
36. WYLLIE AH. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endonuclease activation. Nature, 284, 555-556.
37. ZWELLING AL, MICHAELS S, SCHWARTZ H, DOBSON PP AND KOHN KW. (1981). DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukaemia to cis-diamminedi-chloroplatinum(II) and L-phenylalanine mustard. Cancer Rex., 41, 640-649.